Bibliografía
1. Hettrick DA, Pagel PS, Warltier DC: Desflurane,
sevoflurane, and isoflurane impair canine left ven-
tricular–arterial coupling and mechanical effi-
ciency. Anesthesiology 85:403–413, 1996.
2. Vivien B,Hanouz J-L,Gueugniaud P-Y,et al: Myocar-
dial effects of halothane and isoflurane in hamsters
with hypertrophic cardiomyopathy. Anesthesiology
87:1406–1416, 1997.
3. Hannon JD, Cody MJ, Sun DX, et al: Effects of isoflu-
rane and sevoflurane on intracellular calcium and
contractility in pressure-overload hypertrophy.Anes-
thesiology 101:675–686, 2004.
4. Graham M, Qureshi A, Noueihed R, et al: Effects of
halothane, isoflurane, sevoflurane and desflurane on
contraction of ventricular myocytes from streptozo-
cin-induced diabetic rats. Mol Cell Biochem
261:209–215, 2004.
5. Kersten JR, Schmeling TJ, Pagel PS, et al: Isoflurane
mimics ischemic preconditioning via activation of
K
ATP
channels. Reduction of myocardial infarct size
with an acute memory phase. Anesthesiology
87:361–370, 1997.
6. Pagel PS, Lowe D, Hettrick DA, et al: Isoflurane,
but not halothane, improves indices of diastolic
performance in dogs with rapid ventricular,
pacing-induced cardiomyopathy. Anesthesiology
85:644–654, 1996.
7. An J, Rhodes SS, Jiang MT, et al: Anesthetic precon-
ditioning enhances Ca
2+
handling and mechanical
and metabolic function elicited by Na
D
-Ca
2+
exchange inhibition in isolated hearts. Anesthesio-
logy 105:541–549, 2006.
8. Vivien B, Lecarpentier Y, Riou B, et al: Halothane
and isoflurane do not directly interact with cardiac
cross-bridge function. Anesthesiology 102:364–
370, 2005.
9. Pagel PS,Kehl F,Gare M,et al: Mechanical function
of the left atrium: New insights based on analysis
of pressure-volume relations and Doppler echo-
cardiography. Anesthesiology 98:975–994, 2003.
10. Pagel PS, Hettrick DA, Kersten JR, et al: Isoflurane
and halothane do not alter the enhanced afterload
sensitivity of left ventricular relaxation in dogs with
pacing-induced cardiomyopathy. Anesthesiology
87:952–962, 1997.
11. Heerdt PM, Pleimann BE: The dose-dependent
effects of halothane on right ventricular contraction
pattern and regional inotropy in swine. Anesth
Analg 82:1152–1158, 1996.
12. Heerdt PM, Gandhi CD, Dickstein ML: Disparity of
isoflurane effects on left and right ventricular after-
load and hydraulic power generation in swine.
Anesth Analg 87:511–521, 1998.
13. Hanouz JL, Massetti M, Guesne G, et al: In vitro
effects of desflurane, sevoflurane, isoflurane, and
halothane in isolated human right atria.Anesthesio-
logy 92:116–124, 2000.
14. Gare M, Schwabe DA, Hettrick DA, et al: Desflu-
rane, sevoflurane, and isoflurane affect left atrial
active and passive mechanical properties and
impair left atrial–left ventricular coupling in vivo
Analysis using pressure-volume relations.Anesthe-
siology 95:689–698, 2001.
15. Barbier P, Solomon SB, Schiller NB, et al: Left atrial
relaxation and left ventricular systolic function
determine left atrial reservoir function. Circulation
100:427–436, 1999.
16. Kehl F, LaDisa JF Jr, Hettrick DA, et al: Influence of
isoflurane on left atrial function in dogs with
pacing-induced cardiomyopathy: Evaluation with
pressure-volume relations. J Cardiothorac Vasc
Anesth 17:709–714, 2003.
17. Stowe DF, Marijic J, Bosnjak ZJ, et al: Direct compa-
rative effects of halothane, enflurane, and isoflurane
on oxygen supply and demand in isolated hearts.
Anesthesiology 74:1087–1095, 1991.
18. Crystal GJ, Kim S-J, Czinn EA, et al: Intracoronary
isoflurane causes marked vasodilation in canine
hearts. Anesthesiology 74:757–765, 1991.
19. Hickey RF, Cason BA, Shubayev I: Regional vasodi-
lating properties of isoflurane in normal swine myo-
cardium. Anesthesiology 80:574–581, 1994.
20. Crystal GJ, Kim S-J, Salem MR, et al: Nitric oxide
does not mediate coronary vasodilation by isoflu-
rane. Anesthesiology 81:209–220, 1994.
21. Conzen PF, Habazettl H, Vollmar B, et al: Coronary
microcirculation during halothane, enflurane, iso-
flurane, and adenosine in dogs. Anesthesiology
76:261–270, 1992.
22. Blaise G,ToQ,Parent M,et al:Does halothane interfere
with the release, action, or stability of endothelium-
derived relaxing factor/nitric oxide? Anesthesiology
80:417–426, 1994.
23. Hart JL, Jing M, Bina S, et al: Effects of halothane on
EDRF/cGMP-mediated vascular smooth muscle
relaxations. Anesthesiology 79:323–331, 1993.
24. Yoshida K-I, Okabe E: Selective impairment of
endothelium-dependent relaxation by sevoflurane:
Oxygen free radicals participation. Anesthesiology
76:440–447, 1992.
25. Larach DR, Schuler HG: Potassium channel bloc-
kade and halothane vasodilation in conducting and
resistance coronary arteries. J Pharmacol Exp Ther
267:72–81, 1993.
26. Cason BA, Shubayev I, Hickey RF: Blockade of
adenosine triphosphate–sensitive potassium
channels eliminates isoflurane-induced coro-
nary artery vasodilation. Anesthesiology
81:1245–1255, 1994.
27. Crystal GJ, Gurevicius J, Salem MR, et al: Role of
adenosine triphosphate–sensitive potassium chan-
nels in coronary vasodilation by halothane, isoflu-
rane, and enflurane. Anesthesiology 86:448–458,
1997.
28. Kersten JR,Schmeling TJ,Hettrick DA,et al: Mecha-
nism of cardioprotection by isoflurane: Role of ade-
nosine triphosphate–regulated potassium (K
ATP
)
channels. Anesthesiology 85:794–807, 1996.
29. Pagel PS, Hettrick DA, Lowe D, et al: Desflurane
and isoflurane exert modest beneficial actions on
left ventricular diastolic function during myocar-
dial ischemia in dogs. Anesthesiology 83:1021–
1035, 1995.
30. Hartman JC, Kampine JP, Schmeling WT, et al:
Steal-prone coronary circulation in chronically ins-
trumented dogs: Isoflurane versus adenosine.Anes-
thesiology 74:744–756, 1991.
31. Hartman JC, Kampine JP, SchmelingWT, et al:Vola-
tile anesthetics and regional myocardial perfusion
in chronically instrumented dogs: Halothane versus
isoflurane in a single-vessel disease model with
enhanced collateral development. J Cardiothorac
Anesth 4:588–603, 1990.
32. Hartman JC, Pagel PS, Kampine JP, et al: Influence
of desflurane on the regional distribution of coro-
nary blood flow in a chronically instrumented
canine model of multivessel coronary artery obs-
truction. Anesth Analg 72:289–299, 1991.
33. Kersten JR, Brayer AP, Pagel PS, et al: Perfusion
of ischemic myocardium during anesthesia with
sevoflurane. Anesthesiology 81:995–1004, 1994.
34. Marijic J, Stowe DF, Turner LA, et al: Differential
protective effects of halothane and isoflurane
against hypoxic and reoxygenation injury in the
isolated guinea pig heart. Anesthesiology 73:976–
983, 1990.
35. Novalija E, Fujita S, Kampine JP, et al: Sevoflurane
mimics ischemic preconditioning effects on coro-
nary flow and nitric oxide release in isolated hearts.
Anesthesiology 91:701–712, 1999.
36. Kanaya N, Fujita S: The effects of isoflurane on
regional myocardial contractility and metabolism in
“stunned” myocardium in acutely instrumented
dogs. Anesth Analg 79:447–454, 1994.
37. Lochner A, Harper IS, Salie R, et al: Halothane
protects the isolated rat myocardium against
excessive total intracellular calcium and structu-
ral damage during ischemia and reperfusion.
Anesth Analg 79:226–233, 1994.
38. Cason BA, Gamperl AK, Slocum RE, et al: Anesthe-
tic-induced preconditioning. Previous administra-
tion of isoflurane decreases myocardial infarct size
in rabbits. Anesthesiology 87:1182–1190, 1997.
39. Cope DK, Impastato WK, Cohen MV, et al: Vola-
tile anesthetics protect the ischemic rabbit myo-
cardium
from
infarction. Anesthesiology
86:699–709, 1997.
40. Ludwig LM, Gross GJ, Kersten JR, et al: Morphine
enhances pharmacological preconditioning by iso-
flurane: Role of mitochondrial K
ATP
channels and
opioid receptors. Anesthesiology 98:705–711, 2003.
41. Kehl F, Krolikowski JG, Mraovic B, et al: Is isoflura-
ne-induced preconditioning dose related? Anesthe-
siology 96:675–680, 2002.
42. Zaugg M, Lucchinetti E, Spahn DR, et al: Volatile
anesthetics mimic cardiac preconditioning by
priming the activation of mitochondrial K
ATP
chan-
nels via multiple signaling pathways. Anesthesio-
logy 97:4–14, 2002.
43. Tanaka K,Weihrauch D, Kehl F, et al: Mechanism of
preconditioning by isoflurane in rabbits: A direct
role for reactive oxygen species. Anesthesiology
97:1485–1490, 2002.
44. Toller WG, Kersten JR, Pagel PS, et al: Sevoflurane
reduces myocardial infarct size and decreases the
time threshold for ischemic preconditioning in
dogs. Anesthesiology 91:1437–1446, 1999.
45. Riess ML, Kevin LG, Camara AK, et al: Dual expo-
sure to sevoflurane improves anesthetic precondi-
tioninginintacthearts.Anesthesiology100:569–574,
2004.
46. Kevin LG, Katz P, Camara AK, et al: Anesthetic pre-
conditioning: Effects on latency to ischemic injury
in isolated hearts. Anesthesiology 99:385–391,
2003.
47. Bouwman RA, van’t Hof FN, de Ruijter W, et al: The
mechanism of sevoflurane-induced cardioprotec-
tion is independent of applied ischaemic stimulus
in rat trabeculae. Br J Anaesth 97:307–314, 2006.
48. Sniecinski R, Liu H: Reduced efficacy of volatile
anesthetic preconditioning with advanced age in
isolated rat myocardium. Anesthesiology 100:589–
597, 2004.
49. Riess ML, Camara AK, Rhodes SS, et al: Increasing
heart size and age attenuate anesthetic preconditio-
ning in guinea pig isolated hearts. Anesth Analg
101:1572–1576, 2005.
50. Liu H, Wang L, Eaton M, et al: Sevoflurane precon-
ditioning limits intracellular/mitochondrial Ca
2+
in
ischemic newborn myocardium. Anesth Analg
101:349–355, 2005.
51. Kehl F, Krolikowski JG, Tessmer JP, et al: Increases
in coronary collateral blood flow produced by sevo-
flurane are mediated by calcium-activated potas-
sium (BK
Ca
) channels in vivo. Anesthesiology
97:925–931, 2002.
52. de Klaver MJ, Manning L, Palmer LA, et al: Isoflu-
rane pretreatment inhibits cytokine-induced cell
death in cultured rat smooth muscle cells and
human endothelial cells. Anesthesiology 97:24–32,
2002.
53. Hu G, Salem MR, Crystal GJ: Role of adenosine
receptors in volatile anesthetic preconditioning
against neutrophil-induced contractile dysfunction
in isolated rat hearts. Anesthesiology 103:287–295,
2005.
54. Zaugg M, Lucchinetti E, Uecker M, et al: Anaesthe-
tics and cardiac preconditioning. Part I. Signaling
Farmacología cardiovascular
393
13
Sección II
Farmacología y anestesia
© ELSEVIER. Fotocopiar sin autorización es un delito